(MedPage Today) — FDA advisors on Wednesday will deliberate on whether shunt therapy still has a narrow path forward in heart failure after a disappointing pivotal trial.
In its premarket approval application for the Ventura Interatrial Shunt…
Source link : https://www.medpagetoday.com/cardiology/chf/118788
Author :
Publish date : 2025-12-02 17:41:00
Copyright for syndicated content belongs to the linked Source.
